Therapy News and Research

RSS

Scientists get new motor neurons to migrate through the spinal cord

In experiments with rodents, Johns Hopkins scientists have used properly directed stem cells to successfully overcome what is thought to be a basic hurdle in restoring function to severely damaged central nervous systems

28 Apr 2004

Estimates vary, but as much as 20% of new prescriptions never get filled and 85% of refills never leave the pharmacy

Furthermore, a study conducted by the University of Arizona's School of Pharmacy finds that 40% of patients who receive outpatient drug therapy will experience a treatment failure or new medical problem as a result of improper use.

28 Apr 2004

HIV drug market will grow to an $8 billion industry by 2013

Decision Resources, Inc., a research and advisory firms focusing on pharmaceutical and health care issues, forecasts that the HIV drug market will grow to more than $8 billion by 2013.

28 Apr 2004

$4.5 million contract to develop heart assist devices for infants

The University of Pittsburgh's McGowan Institute for Regenerative Medicine has been awarded a five-year $4.5 million contract from the National Heart, Lung, and Blood Institute to develop a heart assist device for infants.

28 Apr 2004

Serious allergic reactions in cancer patients require expert intervention

Studies show that up to 35 percent of cancer patients are at risk for an allergic reaction to their cancer therapy. Yet, the same drug causing the reaction could be the drug that best helps to control the disease.

28 Apr 2004

$Untreated postmenopausal women with osteoporosis are at risk for first spinal fracture within one year$

Untreated postmenopausal women with osteoporosis are at risk for first spinal fracture within one year

Results of a new analysis found that, without treatment, one out of 13 postmenopausal osteoporotic women who were initially fracture-free were likely to experience a spinal fracture within one year.

28 Apr 2004

Serono says Rebif an effective treatment for brain lesions

New long-term data support the importance of early treatment with high dose, high frequency Rebif® (interferon beta-1a) 44 mcg in reducing the long-term accumulation of brain lesion volume in patients with relapsing remitting multiple sclerosis (MS).

28 Apr 2004

Study shows ZOMIG nasal spray to be an effective treatment for migraine headaches

Results of a new multicenter U.S. study of almost 1,900 patients experiencing more than 3,400 migraine attacks confirm that treatment with ZOMIG(R) (zolmitriptan) Nasal Spray provides a very fast onset of action and long-lasting relief from migraine headache and associated symptoms.

27 Apr 2004

Menopause often wrongly blamed for poor sleep

Middle-aged women often complain that they sleep poorly, and both women and their health care providers point to menopause as the cause. But University of Michigan researchers Jane Lukacs and Nancy Reame say it may be time to put that assumption to rest.

27 Apr 2004

Guidelines include Strattera as an ADHD therapy option

The American Academy of Child and Adolescent Psychiatry (AACAP), the leading professional organization for child and adolescent psychiatry, today issued guidelines that highlight the importance of accurate diagnosis and appropriate treatment of Attention-Deficit/Hyperactivity Disorder (ADHD).

27 Apr 2004

A ten year study shows that surgery is not only effective, but the preferred treatment for select epilepsy patients

A study of ten years of patient outcomes shows that surgery is not only effective, but the preferred treatment for select epilepsy patients. In the most comprehensive study of long-term surgery success rates, Mayo Clinic physicians report that 73 percent of 491 Mayo Clinic patients were either seizure-free or experienced seizures only when medication was discontinued.

27 Apr 2004

Inspire announces positive results in cystic fibrosis study

Inspire Pharmaceuticals, Inc. today announced top-line results in a Phase II study of INS37217 Respiratory in patients with mild cystic fibrosis (CF) lung disease.

27 Apr 2004

Helix BioMedix announces positive results of comparative product anti-wrinkle study

Helix BioMedix today announced that it has completed a 12-week consumer product test comparing the company's anti-wrinkle peptide, HB168 with Renova(R), a currently marketed FDA approved product.

27 Apr 2004

Canadian company requested to ship Dengue Fever test kits to Hong Kong immediately

Medical Services International Inc. has announced that it has been requested to ship VScan Dengue Fever test kits to Hong Kong immediately.

27 Apr 2004

PTSD study focuses on mental window of opportunity

Haunting memories, thoughts, or images are found in Post-Traumatic Stress Disorder (PTSD), a major mental health problem affecting millions worldwide. A new clinical trials study by mental imagery researcher Robert Roerich, M.D. seeks to explore the mind’s ability to heal memory of stressful life experiences.

27 Apr 2004

Landscape architects brighten life of elderly patients with schizophrenia and Alzheimer’s disease

Landscape architects at Manchester Metropolitan University have designed a special garden for elderly patients with schizophrenia and Alzheimer’s disease.

27 Apr 2004

Relieving acute stress from trauma may be a matter of thinking it through

Many people experience serious trauma in their lives - only the fortunate will avoid events such as a serious car accident, the death of a close relative or a physical or sexual assault.

27 Apr 2004

Experts call for better support and understanding of asthma

Leading experts in asthma have called for greater recognition and action amongst healthcare professionals and patients regarding the current status of asthma management across Europe.

26 Apr 2004

Parkinson’s disease drug Pergolide effective in treating restless legs syndrome

Pergolide, a drug commonly used to treat Parkinson’s disease symptoms, has recently been shown to be effective in treating restless legs syndrome. Researchers from seven countries collaborated on the study, published in the April 27 issue of Neurology, the scientific journal of the American Academy of Neurology.

26 Apr 2004

Experimental immune-boosting drug interleukin-2 helps HIV Patients

National Institutes of Health (NIH) scientists report that brief, widely-spaced courses of the experimental immune-boosting drug interleukin-2 (IL-2) allow people with HIV to maintain near normal levels of a key immune system cell for long periods.

26 Apr 2004

Therapy News and Research

Scientists get new motor neurons to migrate through the spinal cord

Estimates vary, but as much as 20% of new prescriptions never get filled and 85% of refills never leave the pharmacy

HIV drug market will grow to an $8 billion industry by 2013

$4.5 million contract to develop heart assist devices for infants

Serious allergic reactions in cancer patients require expert intervention

Untreated postmenopausal women with osteoporosis are at risk for first spinal fracture within one year

Serono says Rebif an effective treatment for brain lesions

Study shows ZOMIG nasal spray to be an effective treatment for migraine headaches

Menopause often wrongly blamed for poor sleep

Guidelines include Strattera as an ADHD therapy option

A ten year study shows that surgery is not only effective, but the preferred treatment for select epilepsy patients

Inspire announces positive results in cystic fibrosis study

Helix BioMedix announces positive results of comparative product anti-wrinkle study

Canadian company requested to ship Dengue Fever test kits to Hong Kong immediately

PTSD study focuses on mental window of opportunity

Landscape architects brighten life of elderly patients with schizophrenia and Alzheimer’s disease

Relieving acute stress from trauma may be a matter of thinking it through

Experts call for better support and understanding of asthma

Parkinson’s disease drug Pergolide effective in treating restless legs syndrome

Experimental immune-boosting drug interleukin-2 helps HIV Patients

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News